Company Profile

BIS Laboratories
Profile last edited on: 1/9/2007      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
----
First Award
1992
Latest Award
1998
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

19231 Victory Boulevard Suite 12
Reseda, CA 91335
   N/A
   N/A
   N/A
Location: Single
Congr. District: 30
County: Los Angeles

Public Profile

On July 1998, IMPATH Inc. (NASDAQ: IMPH) acquired BIS Laboratories. BIS is a leader in the field of lymph node and bone marrow micrometastases analyses focusing exclusively on the ultra-sensitive detection of early dissemination of disease, post-chemotherapy characterization of minimal residual disease and assessment of bone marrow harvested for transplantation.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1998 1 NIH $100,000
Project Title: Invasive Potential Of Occult Breast Cancer In Marrow
1997 2 NIH $799,461
Project Title: In vitro drug senstivity testing of marrow metastases

Key People / Management

  Amy A Ross

  Tehila Umiel

Company News

There are no news available.